| Target Price | $372.30 |
| Price | $320.60 |
| Potential | 16.13% |
| Number of Estimates | 29 |
| 29 Analysts have issued a price target American Express 2027 . The average American Express target price is $372.30. This is 16.13% higher than the current stock price. The highest price target is $446.25 39.19% , the lowest is $323.20 0.81% . | |
| A rating was issued by 35 analysts: 19 Analysts recommend American Express to buy, 16 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the American Express stock has an average upside potential 2027 of 16.13% . Most analysts recommend the American Express stock at Purchase. |
28 Analysts have issued a sales forecast American Express 2026 . The average American Express sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
3 Analysts have issued an American Express EBITDA forecast 2026. The average American Express EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
32 American Express Analysts have issued a net profit forecast 2026. The average American Express net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
American Express...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Nov 02 2026 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Oct 27 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 26 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 26 2026 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 12 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 12 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 09 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Nov 02 2026 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Oct 27 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 26 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 26 2026 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 12 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 12 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 09 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


